{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:52:11Z","timestamp":1791975131698,"version":"4.4.0"},"reference-count":233,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04396-y","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T02:33:58Z","timestamp":1784514838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exosomes in cancer drug resistance: dual roles in therapy failure and emerging precision therapeutics"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6178-8335","authenticated-orcid":false,"given":"Bantayehu Addis","family":"Tegegne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habtamu","family":"Belew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zigale Hibstu","family":"Teffera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mekuriaw","family":"Belayneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desalegn","family":"Abebaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misganaw","family":"Fikrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Jemal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temesgen","family":"Baylie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fasil","family":"Tadesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Agegnew","family":"Wondm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tirsit Ketsela","family":"Zeleke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wubetu Yihunie","family":"Belay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"issue":"1","key":"4396_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA: A Cancer Journal for Clinicians. 2025;75(1):10\u201345.","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"3","key":"4396_CR2","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.18632\/oncotarget.13907","volume":"8","author":"B Son","year":"2017","unstructured":"Son B, Lee S, Youn H, Kim E, Kim W, Youn B. The role of tumor microenvironment in therapeutic resistance. Oncotarget. 2017;8(3):3933\u201345.","journal-title":"Oncotarget"},{"issue":"3","key":"4396_CR3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","volume":"41","author":"EN Arner","year":"2023","unstructured":"Arner EN, Rathmell JC. Metabolic programming and immune suppression in the tumor microenvironment. Cancer Cell. 2023;41(3):421\u201333.","journal-title":"Cancer Cell"},{"key":"4396_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070727","author":"LM Doyle","year":"2019","unstructured":"Doyle LM, Wang MZ. Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8070727.","journal-title":"Cells"},{"key":"4396_CR5","first-page":"2021","volume":"11","author":"Y Zhong","year":"2021","unstructured":"Zhong Y, Li H, Li P, Chen Y, Zhang M, Yuan Z, et al. Exosomes: A New Pathway for Cancer Drug Resistance. Front Oncol. 2021;11:2021.","journal-title":"Front Oncol"},{"issue":"1","key":"4396_CR6","volume":"1875","author":"BC Jena","year":"2021","unstructured":"Jena BC, Mandal M. The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: An insight towards tumor-microenvironment interaction. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2021;1875(1):188488.","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"issue":"4","key":"4396_CR7","first-page":"33","volume":"18","author":"RH Mahmoud","year":"2025","unstructured":"Mahmoud RH, Peterson E, Badiavas EV, Kaminer M, Eber AE. Exosomes: A Comprehensive Review for the Practicing Dermatologist. J Clin Aesthet Dermatol. 2025;18(4):33\u201340.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"1","key":"4396_CR8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s44178-025-00171-7","volume":"4","author":"T Tong","year":"2025","unstructured":"Tong T, Gao W, Jian H, Yang R, Zhang J, Li K, et al. The role and potential mechanisms of exosomes in the progression of hepatocellular carcinoma. Holist Integr Oncol. 2025;4(1):36.","journal-title":"Holist Integr Oncol"},{"key":"4396_CR9","doi-asserted-by":"crossref","first-page":"1379822","DOI":"10.3389\/fmolb.2024.1379822","volume":"11","author":"B Ren","year":"2024","unstructured":"Ren B, Li X, Zhang Z, Tai S, Yu S. Exosomes: a significant medium for regulating drug resistance through cargo delivery. Front Mol Biosci. 2024;11:1379822.","journal-title":"Front Mol Biosci"},{"issue":"8","key":"4396_CR10","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1002\/ctm2.257","volume":"10","author":"S Li","year":"2020","unstructured":"Li S, Yi M, Dong B, Jiao Y, Luo S, Wu K. The roles of exosomes in cancer drug resistance and its therapeutic application. Clin Transl Med. 2020;10(8):e257.","journal-title":"Clin Transl Med"},{"issue":"11","key":"4396_CR11","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s41419-020-03189-z","volume":"11","author":"X Dong","year":"2020","unstructured":"Dong X, Bai X, Ni J, Zhang H, Duan W, Graham P, et al. Exosomes and breast cancer drug resistance. Cell Death Dis. 2020;11(11):987.","journal-title":"Cell Death Dis"},{"key":"4396_CR12","doi-asserted-by":"crossref","unstructured":"Liu L, Jiang D, Bai S, Zhang X, Kang Y. Research progress of exosomes in drug resistance of breast cancer. Front Bioeng Biotechnol. 2024;11:1214648.","DOI":"10.3389\/fbioe.2023.1214648"},{"issue":"4","key":"4396_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41419-023-05753-9","volume":"14","author":"H Luo","year":"2023","unstructured":"Luo H, Zhang H, Mao J, Cao H, Tao Y, Zhao G, et al. Exosome-based nanoimmunotherapy targeting TAMs, a promising strategy for glioma. Cell Death Dis. 2023;14(4):235.","journal-title":"Cell Death Dis"},{"key":"4396_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020. https:\/\/doi.org\/10.1126\/science.aau6977.","journal-title":"Science"},{"issue":"7","key":"4396_CR15","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nbt.2287","volume":"30","author":"SJ Russell","year":"2012","unstructured":"Russell SJ, Peng KW, Bell JC. Oncolytic virotherapy. Nat Biotechnol. 2012;30(7):658\u201370.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"4396_CR16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","volume":"6","author":"JT Bulcha","year":"2021","unstructured":"Bulcha JT, Wang Y, Ma H, Tai PWL, Gao G. Viral vector platforms within the gene therapy landscape. Signal Transduct Target Ther. 2021;6(1):53.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"4396_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41573-019-0029-0","volume":"18","author":"K Harrington","year":"2019","unstructured":"Harrington K, Freeman DJ, Kelly B, Harper J, Soria JC. Optimizing oncolytic virotherapy in cancer treatment. Nat Rev Drug Discov. 2019;18(9):689\u2013706.","journal-title":"Nat Rev Drug Discov"},{"issue":"Pt B","key":"4396_CR18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jconrel.2015.09.031","volume":"220","author":"H Saari","year":"2015","unstructured":"Saari H, L\u00e1zaro-Ib\u00e1\u00f1ez E, Viitala T, Vuorimaa-Laukkanen E, Siljander P, Yliperttula M. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells. J Control Release. 2015;220(Pt B):727\u201337.","journal-title":"J Control Release"},{"key":"4396_CR19","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202000875","author":"KM McAndrews","year":"2021","unstructured":"McAndrews KM, Xiao F, Chronopoulos A, LeBleu VS, Kugeratski FG, Kalluri R. Exosome-mediated delivery of CRISPR\/Cas9 for targeting of oncogenic Kras(G12D) in pancreatic cancer. Life Sci Alliance. 2021. https:\/\/doi.org\/10.26508\/lsa.202000875.","journal-title":"Life Sci Alliance"},{"key":"4396_CR20","first-page":"2024","volume":"15","author":"Z Song","year":"2024","unstructured":"Song Z, Tao Y, Liu Y, Li J. Advances in delivery systems for CRISPR\/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles. Front Immunol. 2024;15:2024.","journal-title":"Front Immunol"},{"issue":"1","key":"4396_CR21","doi-asserted-by":"crossref","first-page":"Fso833","DOI":"10.2144\/fsoa-2022-0032","volume":"9","author":"SH Malgundkar","year":"2023","unstructured":"Malgundkar SH, Tamimi Y. Exosomes as crucial emerging tools for intercellular communication with therapeutic potential in ovarian cancer. Future Sci OA. 2023;9(1):Fso833.","journal-title":"Future Sci OA"},{"key":"4396_CR22","doi-asserted-by":"crossref","first-page":"123468","DOI":"10.1016\/j.lfs.2025.123468","volume":"365","author":"KS Satao","year":"2025","unstructured":"Satao KS, Doshi GM. Intercellular communication via exosomes: A new paradigm in the pathophysiology of neurodegenerative disorders. Life Sci. 2025;365:123468.","journal-title":"Life Sci"},{"key":"4396_CR23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","volume":"30","author":"M Colombo","year":"2014","unstructured":"Colombo M, Raposo G, Th\u00e9ry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255\u201389.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"4","key":"4396_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D\u2019Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213\u201328.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4396_CR25","doi-asserted-by":"publisher","unstructured":"Qi L, Luo D-Z, Li H, Yan J, He W. Macrophage-driven exosomes regulate the progression of cardiovascular disease. Front Pharmacol. 2025;16. https:\/\/doi.org\/10.3389\/fphar.2025.1563800.","DOI":"10.3389\/fphar.2025.1563800"},{"issue":"2","key":"4396_CR26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3892\/or.2017.5714","volume":"38","author":"W Guo","year":"2017","unstructured":"Guo W, Gao Y, Li N, Shao F, Wang C, Wang P, et al. Exosomes: New players in cancer (Review). Oncol Rep. 2017;38(2):665\u201375.","journal-title":"Oncol Rep"},{"issue":"1","key":"4396_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12943-022-01671-0","volume":"21","author":"Q-F Han","year":"2022","unstructured":"Han Q-F, Li W-J, Hu K-S, Gao J, Zhai W-L, Yang J-H, et al. Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer. Mol Cancer. 2022;21(1):207.","journal-title":"Mol Cancer"},{"key":"4396_CR28","doi-asserted-by":"crossref","first-page":"1261651","DOI":"10.3389\/fmicb.2023.1261651","volume":"14","author":"C Wang","year":"2023","unstructured":"Wang C, Chen Y, Hu S, Liu X. Insights into the function of ESCRT and its role in enveloped virus infection. Front Microbiol. 2023;14:1261651.","journal-title":"Front Microbiol"},{"issue":"4","key":"4396_CR29","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s12276-024-01209-y","volume":"56","author":"YJ Lee","year":"2024","unstructured":"Lee YJ, Shin KJ, Chae YC. Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer. Exp Mol Med. 2024;56(4):877\u201389.","journal-title":"Exp Mol Med"},{"issue":"4","key":"4396_CR30","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1016\/j.cub.2012.01.028","volume":"22","author":"O Schmidt","year":"2012","unstructured":"Schmidt O, Teis D. The ESCRT machinery. Curr Biol. 2012;22(4):R116\u201320.","journal-title":"Curr Biol"},{"issue":"11","key":"4396_CR31","doi-asserted-by":"crossref","first-page":"9636","DOI":"10.1074\/jbc.M110.185363","volume":"286","author":"JR Mayers","year":"2011","unstructured":"Mayers JR, Fyfe I, Schuh AL, Chapman ER, Edwardson JM, Audhya A. ESCRT-0 assembles as a heterotetrameric complex on membranes and binds multiple ubiquitinylated cargoes simultaneously. J Biol Chem. 2011;286(11):9636\u201345.","journal-title":"J Biol Chem"},{"issue":"2","key":"4396_CR32","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/tra.12135","volume":"15","author":"SK Mageswaran","year":"2014","unstructured":"Mageswaran SK, Dixon MG, Curtiss M, Keener JP, Babst M. Binding to any ESCRT can mediate ubiquitin-independent cargo sorting. Traffic. 2014;15(2):212\u201329.","journal-title":"Traffic"},{"issue":"7","key":"4396_CR33","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/ncb2502","volume":"14","author":"MF Baietti","year":"2012","unstructured":"Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol. 2012;14(7):677\u201385.","journal-title":"Nat Cell Biol"},{"key":"4396_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315317","author":"R Horbay","year":"2022","unstructured":"Horbay R, Hamraghani A, Ermini L, Holcik S, Beug ST, Yeganeh B. Role of Ceramides and Lysosomes in Extracellular Vesicle Biogenesis, Cargo Sorting and Release. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232315317.","journal-title":"Int J Mol Sci"},{"key":"4396_CR35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2014.04.009","volume":"28","author":"C Villarroya-Beltri","year":"2014","unstructured":"Villarroya-Beltri C, Baixauli F, Guti\u00e9rrez-V\u00e1zquez C, S\u00e1nchez-Madrid F, Mittelbrunn M. Sorting it out: regulation of exosome loading. Semin Cancer Biol. 2014;28:3\u201313.","journal-title":"Semin Cancer Biol"},{"issue":"20","key":"4396_CR36","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.3390\/ijms21207568","volume":"21","author":"J Jankovi\u010dov\u00e1","year":"2020","unstructured":"Jankovi\u010dov\u00e1 J, Se\u010dov\u00e1 P, Michalkov\u00e1 K, Antal\u00edkov\u00e1 J, Tetraspanins. More than Markers of Extracellular Vesicles in Reproduction. Int J Mol Sci. 2020;21(20):7568.","journal-title":"Int J Mol Sci"},{"key":"4396_CR37","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.2147\/IJN.S310357","volume":"16","author":"S Gurunathan","year":"2021","unstructured":"Gurunathan S, Kang MH, Qasim M, Khan K, Kim JH, Biogenesis. Membrane Trafficking, Functions, and Next Generation Nanotherapeutics Medicine of Extracellular Vesicles. Int J Nanomed. 2021;16:3357\u201383.","journal-title":"Int J Nanomed"},{"issue":"1","key":"4396_CR38","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1038\/ncomms4477","volume":"5","author":"R Ghossoub","year":"2014","unstructured":"Ghossoub R, Lembo F, Rubio A, Gaillard CB, Bouchet J, Vitale N, et al. Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2. Nat Commun. 2014;5(1):3477.","journal-title":"Nat Commun"},{"issue":"9","key":"4396_CR39","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1194\/jlr.R083964","volume":"59","author":"AL Egea-Jimenez","year":"2018","unstructured":"Egea-Jimenez AL, Zimmermann P. Phospholipase D and phosphatidic acid in the biogenesis and cargo loading of extracellular vesicles. J Lipid Res. 2018;59(9):1554\u201360.","journal-title":"J Lipid Res"},{"issue":"3","key":"4396_CR40","volume":"9","author":"Y Fan","year":"2022","unstructured":"Fan Y, Li Z, He Y. Exosomes in the pathogenesis, progression, and treatment of osteoarthritis. Bioengineering. 2022;9(3):99.","journal-title":"Bioengineering"},{"key":"4396_CR41","doi-asserted-by":"publisher","unstructured":"Willms E, Caba\u00f1as C, M\u00e4ger I, Wood MJA, Vader P. Extracellular vesicle heterogeneity: subpopulations, isolation techniques, and diverse functions in cancer progression. Front Immunol. 2018;9:738. https:\/\/doi.org\/10.3389\/fimmu.2018.00738.","DOI":"10.3389\/fimmu.2018.00738"},{"key":"4396_CR42","doi-asserted-by":"crossref","first-page":"101280","DOI":"10.1016\/j.neo.2026.101280","volume":"73","author":"J Zhang","year":"2026","unstructured":"Zhang J, Gu Y, Zhao F, Chen Y, Xia Y, Gao D, et al. Targeting the ANXA2-CD63-exosomal PD-L1 axis in hepatocellular carcinoma: A novel mechanism of immune evasion and its implications for precision immunotherapy. Neoplasia. 2026;73:101280.","journal-title":"Neoplasia"},{"key":"4396_CR43","volume":"12","author":"L Dong","year":"2025","unstructured":"Dong L, Zheng S, Feng Y. Hypoxia-induced immunosuppression in uveal melanoma is mediated by CD63(+) exosomes delivering lactate to reprogram immune cells. Frontiers in Molecular Biosciences. 2025;12:1743009.","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"1","key":"4396_CR44","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1038\/s41467-021-24384-2","volume":"12","author":"M Mathieu","year":"2021","unstructured":"Mathieu M, N\u00e9vo N, Jouve M, Valenzuela JI, Maurin M, Verweij FJ, et al. Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9. Nat Commun. 2021;12(1):4389.","journal-title":"Nat Commun"},{"issue":"745","key":"4396_CR45","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abg8191","volume":"15","author":"J Nigri","year":"2022","unstructured":"Nigri J, Leca J, Tubiana SS, Finetti P, Guillaumond F, Martinez S, et al. CD9 mediates the uptake of extracellular vesicles from cancer-associated fibroblasts that promote pancreatic cancer cell aggressiveness. Science Signaling. 2022;15(745):eabg8191.","journal-title":"Science Signaling"},{"key":"4396_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/biology12010110","author":"M Sheta","year":"2023","unstructured":"Sheta M, Taha EA, Lu Y, Eguchi T. Extracellular Vesicles: New Classification and Tumor Immunosuppression. Biology (Basel). 2023. https:\/\/doi.org\/10.3390\/biology12010110.","journal-title":"Biology (Basel)"},{"issue":"1","key":"4396_CR47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41565-024-01774-3","volume":"20","author":"RP Carney","year":"2025","unstructured":"Carney RP, Mizenko RR, Bozkurt BT, Lowe N, Henson T, Arizzi A, et al. Harnessing extracellular vesicle heterogeneity for diagnostic and therapeutic applications. Nature Nanotechnology. 2025;20(1):14\u201325.","journal-title":"Nature Nanotechnology"},{"key":"4396_CR48","volume":"2022","author":"Y Li","year":"2022","unstructured":"Li Y, Meng L, Li B, Li Y, Shen T, Zhao B. The exosome journey: from biogenesis to regulation and function in cancers. J Oncol. 2022;2022:9356807.","journal-title":"J Oncol"},{"issue":"4","key":"4396_CR49","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s12276-024-01209-y","volume":"56","author":"YJ Lee","year":"2024","unstructured":"Lee YJ, Shin KJ, Chae YC. Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer. Exp Mol Med. 2024;56(4):877\u201389.","journal-title":"Exp Mol Med"},{"issue":"2","key":"4396_CR50","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bbcan.2019.04.004","volume":"1871","author":"L Zhang","year":"2019","unstructured":"Zhang L, Yu D. Exosomes in cancer development, metastasis, and immunity. Biochim Biophys Acta Rev Cancer. 2019;1871(2):455\u201368.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"2","key":"4396_CR51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s13402-024-00990-2","volume":"48","author":"S Araujo-Abad","year":"2025","unstructured":"Araujo-Abad S, Berna JM, Lloret-Lopez E, L\u00f3pez-Cort\u00e9s A, Saceda M, de Juan Romero C. Exosomes: from basic research to clinical diagnostic and therapeutic applications in cancer. Cell Oncol. 2025;48(2):269\u201393.","journal-title":"Cell Oncol"},{"key":"4396_CR52","doi-asserted-by":"crossref","first-page":"117296","DOI":"10.1016\/j.biopha.2024.117296","volume":"179","author":"J Ye","year":"2024","unstructured":"Ye J, Li D, Jie Y, Luo H, Zhang W, Qiu C. Exosome-based nanoparticles and cancer immunotherapy. Biomed Pharmacother. 2024;179:117296.","journal-title":"Biomed Pharmacother"},{"issue":"3\u20134","key":"4396_CR53","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10555-013-9441-9","volume":"32","author":"AS Azmi","year":"2013","unstructured":"Azmi AS, Bao B, Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev. 2013;32(3\u20134):623\u201342.","journal-title":"Cancer Metastasis Rev"},{"key":"4396_CR54","doi-asserted-by":"crossref","first-page":"454837","DOI":"10.1155\/2015\/454837","volume":"2015","author":"C Soekmadji","year":"2015","unstructured":"Soekmadji C, Nelson CC. The Emerging Role of Extracellular Vesicle-Mediated Drug Resistance in Cancers: Implications in Advanced Prostate Cancer. Biomed Res Int. 2015;2015:454837.","journal-title":"Biomed Res Int"},{"key":"4396_CR55","doi-asserted-by":"publisher","unstructured":"Andreu Z, Y\u00e1\u00f1ez-M\u00f3 M. Tetraspanins in extracellular vesicle formation and function. Front Immunol. 2014;5:442. https:\/\/doi.org\/10.3389\/fimmu.2014.00442.","DOI":"10.3389\/fimmu.2014.00442"},{"issue":"1737","key":"4396_CR56","doi-asserted-by":"crossref","first-page":"20160479","DOI":"10.1098\/rstb.2016.0479","volume":"373","author":"M Tkach","year":"2018","unstructured":"Tkach M, Kowal J, Th\u00e9ry C. Why the need and how to approach the functional diversity of extracellular vesicles. Philosophical Trans Royal Soc B: Biol Sci. 2018;373(1737):20160479.","journal-title":"Philosophical Trans Royal Soc B: Biol Sci"},{"key":"4396_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207568","author":"J Jankovi\u010dov\u00e1","year":"2020","unstructured":"Jankovi\u010dov\u00e1 J, Se\u010dov\u00e1 P, Michalkov\u00e1 K, Antal\u00edkov\u00e1 J. Tetraspanins, More than Markers of Extracellular Vesicles in Reproduction. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21207568.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4396_CR58","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s43046-025-00289-9","volume":"37","author":"S Sonwane","year":"2025","unstructured":"Sonwane S, Telrandhe U, Chambhare N, Vaidya S. Unraveling exosome-mediated cancer therapy resistance: pathways and therapeutic challenges. J Egypt Natl Cancer Inst. 2025;37(1):30.","journal-title":"J Egypt Natl Cancer Inst"},{"issue":"4","key":"4396_CR59","first-page":"228","volume":"75","author":"A Vu\u010demilovi\u0107","year":"2024","unstructured":"Vu\u010demilovi\u0107 A. Exosomes: intriguing mediators of intercellular communication in the organism\u2019s response to noxious agents. Arh Hig Rada Toksikol. 2024;75(4):228\u201339.","journal-title":"Arh Hig Rada Toksikol"},{"issue":"8","key":"4396_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0295-2","volume":"51","author":"DH Kim","year":"2019","unstructured":"Kim DH, Kim H, Choi YJ, Kim SY, Lee J-E, Sung KJ, et al. Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer. Exp Mol Med. 2019;51(8):1\u201313.","journal-title":"Exp Mol Med"},{"issue":"7","key":"4396_CR61","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.trecan.2020.03.002","volume":"6","author":"SM Morrissey","year":"2020","unstructured":"Morrissey SM, Yan J. Exosomal PD-L1: Roles in Tumor Progression and Immunotherapy. Trends Cancer. 2020;6(7):550\u20138.","journal-title":"Trends Cancer"},{"key":"4396_CR62","doi-asserted-by":"publisher","unstructured":"Kansha T, Ma X, Wang H, Yu X, Song Y, Guo Z et al. Exosomal PD-L1 detection in cancer predictive biomarker for response to immune checkpoint blockade therapy. Front Immunol. 2025;16:1603855. https:\/\/doi.org\/10.3389\/fimmu.2025.1603855.","DOI":"10.3389\/fimmu.2025.1603855"},{"key":"4396_CR63","doi-asserted-by":"crossref","first-page":"569219","DOI":"10.3389\/fcell.2020.569219","volume":"8","author":"K Zhou","year":"2020","unstructured":"Zhou K, Guo S, Li F, Sun Q, Liang G. Exosomal PD-L1: New Insights Into Tumor Immune Escape Mechanisms and Therapeutic Strategies. Front Cell Dev Biol. 2020;8:569219.","journal-title":"Front Cell Dev Biol"},{"key":"4396_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/cells11182791","author":"J Rhim","year":"2022","unstructured":"Rhim J, Baek W, Seo Y, Kim JH. From Molecular Mechanisms to Therapeutics: Understanding MicroRNA-21 in Cancer. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11182791.","journal-title":"Cells"},{"key":"4396_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158264","author":"S Gupta","year":"2024","unstructured":"Gupta S, Silveira DA, Lorenzoni PR, Mombach JCM, Hashimoto RF. LncRNA PTENP1\/miR-21\/PTEN Axis Modulates EMT and Drug Resistance in Cancer: Dynamic Boolean Modeling for Cell Fates in DNA Damage Response. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25158264.","journal-title":"Int J Mol Sci"},{"key":"4396_CR66","doi-asserted-by":"publisher","unstructured":"Tian L, Lu J, Ng IO-L. Extracellular vesicles and cancer stemness in hepatocellular carcinoma \u2013 is there a link? Front Immunol. 2024;15{1368898. https:\/\/doi.org\/10.3389\/fimmu.2024.1368898.","DOI":"10.3389\/fimmu.2024.1368898"},{"key":"4396_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122613","author":"C Lecerf","year":"2020","unstructured":"Lecerf C, Peperstraete E, Le Bourhis X, Adriaenssens E. Propagation and Maintenance of Cancer Stem Cells: A Major Influence of the Long Non-Coding RNA H19. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9122613.","journal-title":"Cells"},{"issue":"1","key":"4396_CR68","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s13287-024-04061-z","volume":"15","author":"Q Li","year":"2024","unstructured":"Li Q, He G, Yu Y, Li X, Peng X, Yang L. Exosome crosstalk between cancer stem cells and tumor microenvironment: cancer progression and therapeutic strategies. Stem Cell Res Ther. 2024;15(1):449.","journal-title":"Stem Cell Res Ther"},{"key":"4396_CR69","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1038\/ncomms3980","volume":"4","author":"C Villarroya-Beltri","year":"2013","unstructured":"Villarroya-Beltri C, Guti\u00e9rrez-V\u00e1zquez C, S\u00e1nchez-Cabo F, P\u00e9rez-Hern\u00e1ndez D, V\u00e1zquez J, Martin-Cofreces N, et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun. 2013;4:2980.","journal-title":"Nat Commun"},{"issue":"1","key":"4396_CR70","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00432-025-06382-9","volume":"152","author":"P Tabnak","year":"2025","unstructured":"Tabnak P, Ebrahimnezhad M. Insights into SUMOylation in gastric cancer: molecular mechanisms and emerging therapeutic opportunities. J Cancer Res Clin Oncol. 2025;152(1):2.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"4396_CR71","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s13046-023-02854-3","volume":"42","author":"S Zheng","year":"2023","unstructured":"Zheng S, Tian Q, Yuan Y, Sun S, Li T, Xia R, et al. Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer. J Experimental Clin Cancer Res. 2023;42(1):324.","journal-title":"J Experimental Clin Cancer Res"},{"issue":"8","key":"4396_CR72","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1093\/nar\/gkac237","volume":"50","author":"MJ Cabello-Lobato","year":"2022","unstructured":"Cabello-Lobato MJ, Jenner M, Cisneros-Aguirre M, Br\u00fcninghoff K, Sandy Z, da Costa IC, et al. Microarray screening reveals two non-conventional SUMO-binding modules linked to DNA repair by non-homologous end-joining. Nucleic Acids Res. 2022;50(8):4732\u201354.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"4396_CR73","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1042\/BST20230862","volume":"52","author":"JS Bhachoo","year":"2024","unstructured":"Bhachoo JS, Garvin AJ. SUMO and the DNA damage response. Biochem Soc Trans. 2024;52(2):773\u201392.","journal-title":"Biochem Soc Trans"},{"key":"4396_CR74","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/bs.acr.2018.05.004","volume":"140","author":"A Elsherbini","year":"2018","unstructured":"Elsherbini A, Bieberich E. Ceramide and Exosomes: A Novel Target in Cancer Biology and Therapy. Adv Cancer Res. 2018;140:121\u201354.","journal-title":"Adv Cancer Res"},{"key":"4396_CR75","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2017.10.020","volume":"268","author":"J Wang","year":"2017","unstructured":"Wang J, Yeung BZ, Cui M, Peer CJ, Lu Z, Figg WD, et al. Exosome is a mechanism of intercellular drug transfer: Application of quantitative pharmacology. J Control Release. 2017;268:147\u201358.","journal-title":"J Control Release"},{"key":"4396_CR76","doi-asserted-by":"publisher","unstructured":"Gu X-Y, Yang J-L, Lai R, Zhou Z-J, Tang D, Hu L et al. Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives. Front Immunol. 2025;16. https:\/\/doi.org\/10.3389\/fimmu.2025.1563303.","DOI":"10.3389\/fimmu.2025.1563303"},{"key":"4396_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218363","author":"JX Wang","year":"2020","unstructured":"Wang JX, Choi SYC, Niu X, Kang N, Xue H, Killam J, et al. Lactic Acid and an Acidic Tumor Microenvironment suppress Anticancer Immunity. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21218363.","journal-title":"Int J Mol Sci"},{"key":"4396_CR78","first-page":"2024","volume":"15","author":"M Jiang","year":"2024","unstructured":"Jiang M, Wang Y, Zhao X, Yu J. From metabolic byproduct to immune modulator: the role of lactate in tumor immune escape. Front Immunol. 2024;15:2024.","journal-title":"Front Immunol"},{"key":"4396_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113244","author":"R P\u00e9rez-Tom\u00e1s","year":"2020","unstructured":"P\u00e9rez-Tom\u00e1s R, P\u00e9rez-Guill\u00e9n I. Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12113244.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"4396_CR80","first-page":"189339","volume":"1880","author":"C Gao","year":"2025","unstructured":"Gao C, Li J, Shan B. Research progress on the regulatory role of lactate and lactylation in tumor microenvironment. Biochimica et Biophysica Acta (BBA) -. Reviews Cancer. 2025;1880(3):189339.","journal-title":"Reviews Cancer"},{"issue":"2","key":"4396_CR81","doi-asserted-by":"crossref","first-page":"e70114","DOI":"10.1002\/cph4.70114","volume":"16","author":"Y Chen","year":"2026","unstructured":"Chen Y, Yuan Y, Zhang Z, Shi Y. The Exosome-Lactate-Lactylation Axis: A Metabolic-Epigenetic Circuit Driving Tumor Immune Evasion. Compr Physiol. 2026;16(2):e70114.","journal-title":"Compr Physiol"},{"key":"4396_CR82","doi-asserted-by":"crossref","first-page":"1573039","DOI":"10.3389\/fimmu.2025.1573039","volume":"16","author":"X Jin","year":"2025","unstructured":"Jin X, Zhang N, Yan T, Wei J, Hao L, Sun C, et al. Lactate-mediated metabolic reprogramming of tumor-associated macrophages: implications for tumor progression and therapeutic potential. Front Immunol. 2025;16:1573039.","journal-title":"Front Immunol"},{"issue":"10","key":"4396_CR83","doi-asserted-by":"crossref","first-page":"e13478","DOI":"10.1111\/cpr.13478","volume":"56","author":"T Wang","year":"2023","unstructured":"Wang T, Ye Z, Li Z, Jing DS, Fan GX, Liu MQ, et al. Lactate-induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer. Cell Prolif. 2023;56(10):e13478.","journal-title":"Cell Prolif"},{"issue":"3","key":"4396_CR84","first-page":"e00020","volume":"3","author":"Y Heng","year":"2025","unstructured":"Heng Y, Yu Z, Chen L, Zhou Y. Lactylation in Gynecological Malignancies: A Bridge between Lactate Metabolism and Epigenetic Therapy. Oncol Adv. 2025;3(3):e00020.","journal-title":"Oncol Adv"},{"key":"4396_CR85","doi-asserted-by":"publisher","unstructured":"Xie Y, Hu H, Liu M, Zhou T, Cheng X, Huang W et al. The role and mechanism of histone lactylation in health and diseases. Front Genet. 2022;13:949252. https:\/\/doi.org\/10.3389\/fgene.2022.949252949252.","DOI":"10.3389\/fgene.2022.949252949252"},{"key":"4396_CR86","doi-asserted-by":"crossref","first-page":"11371","DOI":"10.2147\/DDDT.S567488","volume":"19","author":"Y Wang","year":"2025","unstructured":"Wang Y, Chen J, Wang Y, Cao Y, Li Y, Zhu Y, et al. Targeting Lactylation Offers Therapy to Reverse Cell Death Resistance. Drug Des Devel Ther. 2025;19:11371\u201394.","journal-title":"Drug Des Devel Ther"},{"issue":"7779","key":"4396_CR87","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575\u201380.","journal-title":"Nature"},{"key":"4396_CR88","doi-asserted-by":"crossref","first-page":"1661697","DOI":"10.3389\/fmolb.2025.1661697","volume":"12","author":"J Jia","year":"2025","unstructured":"Jia J, Liu N, Zhu X, Chen M. Insights into recent findings and therapeutic potential of nonhistone lactylation in cancer. Front Mol Biosci. 2025;12:1661697.","journal-title":"Front Mol Biosci"},{"key":"4396_CR89","doi-asserted-by":"publisher","unstructured":"Lv Z, Yang R, Liu L, Shi X, Wang R, Wu J et al. Lactylation as a cross-regulatory node in tumor metabolism and epigenetics: insights and therapeutic implications. Front Immunol. 2025;16. https:\/\/doi.org\/10.3389\/fimmu.2025.1675480.","DOI":"10.3389\/fimmu.2025.1675480"},{"key":"4396_CR90","first-page":"39","volume":"8","author":"C Li","year":"2025","unstructured":"Li C, Liu Z, Kong D, Li Z, Li L. Lactylation: a novel driver of drug resistance in the tumor microenvironment. Cancer Drug Resist. 2025;8:39.","journal-title":"Cancer Drug Resist"},{"key":"4396_CR91","doi-asserted-by":"publisher","unstructured":"Yang Q, Yang Z, Zhao H. Lactylation in cancer: mechanistic insights, tumor microenvironment, and therapeutic horizons. Front Immunol. 2026;16:1697008. https:\/\/doi.org\/10.3389\/fimmu.2025.1697008.","DOI":"10.3389\/fimmu.2025.1697008"},{"issue":"1","key":"4396_CR92","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1080\/14756366.2020.1754814","volume":"35","author":"H Zhang","year":"2020","unstructured":"Zhang H, Lu J, Liu J, Zhang G, Lu A. Advances in the discovery of exosome inhibitors in cancer. J Enzyme Inhib Med Chem. 2020;35(1):1322\u201330.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"4","key":"4396_CR93","doi-asserted-by":"crossref","first-page":"e18138","DOI":"10.1111\/jcmm.18138","volume":"28","author":"N Irep","year":"2024","unstructured":"Irep N, Inci K, Tokgun PE, Tokgun O. Exosome inhibition improves response to first-line therapy in small cell lung cancer. J Cell Mol Med. 2024;28(4):e18138.","journal-title":"J Cell Mol Med"},{"issue":"7693","key":"4396_CR94","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138.","journal-title":"Nature"},{"issue":"7718","key":"4396_CR95","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","volume":"560","author":"G Chen","year":"2018","unstructured":"Chen G, Huang AC, Zhang W, Zhang G, Wu M, Xu W, et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature. 2018;560(7718):382\u20136.","journal-title":"Nature"},{"issue":"1","key":"4396_CR96","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12943-020-01167-9","volume":"19","author":"H Zhu","year":"2020","unstructured":"Zhu H, Wei M, Xu J, Hua J, Liang C, Meng Q, et al. PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications. Mol Cancer. 2020;19(1):49.","journal-title":"Mol Cancer"},{"issue":"1","key":"4396_CR97","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10555-021-09992-0","volume":"41","author":"I Garrido-Cano","year":"2022","unstructured":"Garrido-Cano I, Pattanayak B, Adam-Artigues A, Lameirinhas A, Torres-Ruiz S, Tormo E, et al. MicroRNAs as a clue to overcome breast cancer treatment resistance. Cancer Metastasis Rev. 2022;41(1):77\u2013105.","journal-title":"Cancer Metastasis Rev"},{"issue":"2","key":"4396_CR98","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1182\/bloodadvances.2020002439","volume":"5","author":"AS Advani","year":"2021","unstructured":"Advani AS, Larsen E, Laumann K, Luger SM, Liedtke M, Devidas M, et al. Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia. Blood Adv. 2021;5(2):504\u201312.","journal-title":"Blood Adv"},{"issue":"3","key":"4396_CR99","doi-asserted-by":"crossref","first-page":"151337","DOI":"10.1016\/j.ejcb.2023.151337","volume":"102","author":"J Alizadeh","year":"2023","unstructured":"Alizadeh J, da Silva Rosa SC, Weng X, Jacobs J, Lorzadeh S, Ravandi A, et al. Ceramides and ceramide synthases in cancer: Focus on apoptosis and autophagy. Eur J Cell Biol. 2023;102(3):151337.","journal-title":"Eur J Cell Biol"},{"issue":"1","key":"4396_CR100","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1038\/ncomms3980","volume":"4","author":"C Villarroya-Beltri","year":"2013","unstructured":"Villarroya-Beltri C, Guti\u00e9rrez-V\u00e1zquez C, S\u00e1nchez-Cabo F, P\u00e9rez-Hern\u00e1ndez D, V\u00e1zquez J, Martin-Cofreces N, et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun. 2013;4(1):2980.","journal-title":"Nat Commun"},{"issue":"4","key":"4396_CR101","first-page":"189373","volume":"1880","author":"F Gao","year":"2025","unstructured":"Gao F, Sun K, Wang S, Zhang X, Bai X. Lactate metabolism reprogramming in PDAC: Potential for tumor therapy. Biochimica et Biophysica Acta (BBA) -. Reviews Cancer. 2025;1880(4):189373.","journal-title":"Reviews Cancer"},{"issue":"1","key":"4396_CR102","volume":"10","author":"J Chen","year":"2025","unstructured":"Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y, et al. Lactate and lactylation in cancer. Signal Transduction and Targeted Therapy. 2025;10(1):38.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"4396_CR103","doi-asserted-by":"publisher","unstructured":"Mercogliano MF, Bruni S, Mauro FL, Schillaci R. Emerging targeted therapies for HER2-positive breast cancer. Cancers (Basel). 2023;15(7):1987. https:\/\/doi.org\/10.3390\/cancers15071987.","DOI":"10.3390\/cancers15071987"},{"key":"4396_CR104","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102187","volume":"51","author":"A Rusak","year":"2025","unstructured":"Rusak A, Wiatrak B, Krawczy\u0144ska K, G\u00f3rnicki T, Zag\u00f3rski K, Zadka \u0141, et al. Starting points for the development of new targeted therapies for glioblastoma multiforme. Translational Oncology. 2025;51:102187.","journal-title":"Translational Oncology"},{"issue":"3","key":"4396_CR105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/156800912799277557","volume":"12","author":"TE Taylor","year":"2012","unstructured":"Taylor TE, Furnari FB, Cavenee WK. Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance. Curr Cancer Drug Targets. 2012;12(3):197\u2013209.","journal-title":"Curr Cancer Drug Targets"},{"issue":"4","key":"4396_CR106","doi-asserted-by":"crossref","DOI":"10.3390\/genes15040501","volume":"15","author":"D Roda","year":"2024","unstructured":"Roda D, Veiga P, Melo JB, Carreira IM, Ribeiro IP. Principles in the management of glioblastoma. Genes. 2024;15(4):501.","journal-title":"Genes"},{"issue":"1","key":"4396_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02854-3","volume":"42","author":"S Zheng","year":"2023","unstructured":"Zheng S, Tian Q, Yuan Y, Sun S, Li T, Xia R, et al. Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer. J Exp Clin Cancer Res. 2023;42(1):324.","journal-title":"J Exp Clin Cancer Res"},{"key":"4396_CR108","first-page":"43","volume":"7","author":"W Pan","year":"2024","unstructured":"Pan W, Miao Q, Yin W, Li X, Ye W, Zhang D, et al. The role and clinical applications of exosomes in cancer drug resistance. Cancer Drug Resist. 2024;7:43.","journal-title":"Cancer Drug Resist"},{"issue":"34","key":"4396_CR109","doi-asserted-by":"crossref","first-page":"2201609","DOI":"10.1002\/advs.202201609","volume":"9","author":"Q Yang","year":"2022","unstructured":"Yang Q, Xu J, Gu J, Shi H, Zhang J, Zhang J, et al. Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications. Adv Sci. 2022;9(34):2201609.","journal-title":"Adv Sci"},{"issue":"24","key":"4396_CR110","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1002\/cam4.4830","volume":"11","author":"Y Pan","year":"2022","unstructured":"Pan Y, Tang H, Li Q, Chen G, Li D. Exosomes and their roles in the chemoresistance of pancreatic cancer. Cancer Med. 2022;11(24):4979\u201388.","journal-title":"Cancer Med"},{"issue":"1","key":"4396_CR111","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s13046-023-02854-3","volume":"42","author":"S Zheng","year":"2023","unstructured":"Zheng S, Tian Q, Yuan Y, Sun S, Li T, Xia R, et al. Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer. J Experimental Clin Cancer Res. 2023;42(1):324.","journal-title":"J Experimental Clin Cancer Res"},{"issue":"11","key":"4396_CR112","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.32604\/or.2025.066150","volume":"33","author":"C Yang","year":"2025","unstructured":"Yang C, Wang Z, Bi S, Zhang X, Xu Z, Ge Y, et al. Exosomal Non-Coding RNAs in Pancreatic Cancer: From Mechanisms to Clinical Applications. Oncol Res. 2025;33(11):3207\u201329.","journal-title":"Oncol Res"},{"key":"4396_CR113","doi-asserted-by":"publisher","unstructured":"Mir R, Jan U, Barnawi J, Algehainy NA, Jalal MM, Altayar MA et al. Extracellular derived-exosomal micrornas in pancreatic cancer: investigating their diagnostic importance and potential targets for the prevention and treatment in pancreatic cancer. Front Oncol. 2025;15:1669213. https:\/\/doi.org\/10.3389\/fonc.2025.1669213.","DOI":"10.3389\/fonc.2025.1669213"},{"issue":"11","key":"4396_CR114","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1158\/0008-5472.CAN-09-4467","volume":"70","author":"E Giovannetti","year":"2010","unstructured":"Giovannetti E, Funel N, Peters GJ, Del Chiaro M, Erozenci LA, Vasile E, et al. MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity. Cancer Res. 2010;70(11):4528\u201338.","journal-title":"Cancer Res"},{"issue":"5","key":"4396_CR115","doi-asserted-by":"crossref","first-page":"730","DOI":"10.17305\/bb.2025.13295","volume":"26","author":"O Mohammed","year":"2025","unstructured":"Mohammed O, Ahmed Assaye M, Alemayehu E, Tufa A, Genet S. Exosomes in cancer metabolism and drug resistance: A review. Biomol Biomed. 2025;26(5):730\u201345.","journal-title":"Biomol Biomed"},{"issue":"3","key":"4396_CR116","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4103\/tcmj.tcmj_62_25","volume":"37","author":"Y Yen","year":"2025","unstructured":"Yen Y, Chu TY, Tseng RC. Exosomal long noncoding RNAs and microRNAs in colorectal cancer. Tzu Chi Med J. 2025;37(3):235\u201346.","journal-title":"Tzu Chi Med J"},{"key":"4396_CR117","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3389\/fonc.2019.00521","volume":"9","author":"F Mannavola","year":"2019","unstructured":"Mannavola F, Salerno T, Passarelli A, Tucci M, Intern\u00f2 V, Silvestris F. Revisiting the role of exosomes in colorectal cancer: where are we now? Front Oncol. 2019;9:521. https:\/\/doi.org\/10.3389\/fonc.2019.00521.","journal-title":"Front Oncol"},{"key":"4396_CR118","doi-asserted-by":"publisher","unstructured":"Lampropoulou DI, Pliakou E, Aravantinos G, Filippou D, Gazouli M. The role of exosomal non-coding RNAs in colorectal cancer drug resistance. Int J Mol Sci. 2022;23(3):1473. https:\/\/doi.org\/10.3390\/ijms23031473.","DOI":"10.3390\/ijms23031473"},{"issue":"6","key":"4396_CR119","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H, Ekstr\u00f6m K, Bossios A, Sj\u00f6strand M, Lee JJ, L\u00f6tvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654\u20139.","journal-title":"Nat Cell Biol"},{"issue":"31","key":"4396_CR120","doi-asserted-by":"crossref","first-page":"50086","DOI":"10.18632\/oncotarget.10574","volume":"7","author":"L Lugini","year":"2016","unstructured":"Lugini L, Valtieri M, Federici C, Cecchetti S, Meschini S, Condello M, et al. Exosomes from human colorectal cancer induce a tumor-like behavior in colonic mesenchymal stromal cells. Oncotarget. 2016;7(31):50086\u201398.","journal-title":"Oncotarget"},{"issue":"11","key":"4396_CR121","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.7150\/jca.84930","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Li X, Zhang T, Liu G. The roles of exosomes in ovarian cancer chemo-resistance. J Cancer. 2023;14(11):2128.","journal-title":"J Cancer"},{"key":"4396_CR122","doi-asserted-by":"publisher","first-page":"11150","DOI":"10.1038\/ncomms11150","volume":"7","author":"CL Au Yeung","year":"2016","unstructured":"Au Yeung CL, Co NN, Tsuruga T, Yeung TL, Kwan SY, Leung CS, et al. Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1. Nat Commun. 2016;7:11150.","journal-title":"Nat Commun"},{"key":"4396_CR123","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bioactmat.2021.08.029","volume":"10","author":"A Thakur","year":"2022","unstructured":"Thakur A, Parra DC, Motallebnejad P, Brocchi M, Chen HJ. Exosomes: Small vesicles with big roles in cancer, vaccine development, and therapeutics. Bioactive Mater. 2022;10:281\u201394.","journal-title":"Bioactive Mater"},{"issue":"11","key":"4396_CR124","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/s12276-022-00898-7","volume":"54","author":"JH Kim","year":"2022","unstructured":"Kim JH, Lee CH, Baek MC. Dissecting exosome inhibitors: therapeutic insights into small-molecule chemicals against cancer. Exp Mol Med. 2022;54(11):1833\u201343.","journal-title":"Exp Mol Med"},{"key":"4396_CR125","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.2147\/IJN.S464249","volume":"19","author":"M Bahadorani","year":"2024","unstructured":"Bahadorani M, Nasiri M, Dellinger K, Aravamudhan S, Zadegan R. Engineering Exosomes for Therapeutic Applications: Decoding Biogenesis, Content Modification, and Cargo Loading Strategies. Int J Nanomed. 2024;19:7137\u201364.","journal-title":"Int J Nanomed"},{"key":"4396_CR126","doi-asserted-by":"crossref","unstructured":"Gabaran SG, Nejati V, Dilsiz N, Rezaie J. An updated review on the inhibition of exosome biogenesis, release, and uptake: a potential anticancer approach. Biochem Pharmacol. 2025;239:117019.","DOI":"10.1016\/j.bcp.2025.117019"},{"issue":"9","key":"4396_CR127","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s12276-022-00856-3","volume":"54","author":"Y Li","year":"2022","unstructured":"Li Y, Chen Z-K, Duan X, Zhang H-J, Xiao B-L, Wang K-M, et al. Targeted inhibition of tumor-derived exosomes as a novel therapeutic option for cancer. Exp Mol Med. 2022;54(9):1379\u201389.","journal-title":"Exp Mol Med"},{"key":"4396_CR128","doi-asserted-by":"crossref","unstructured":"Choezom D, Gross JC. Neutral sphingomyelinase 2 controls exosome secretion by counteracting V-ATPase-mediated endosome acidification. J Cell Sci. 2022;135(5):jcs259324.","DOI":"10.1242\/jcs.259324"},{"key":"4396_CR129","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15071992","author":"NCH Lau","year":"2023","unstructured":"Lau NCH, Yam JWP. From exosome biogenesis to absorption: key takeaways for cancer research. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15071992.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4396_CR130","doi-asserted-by":"crossref","first-page":"1703244","DOI":"10.1080\/20013078.2019.1703244","volume":"9","author":"M Catalano","year":"2020","unstructured":"Catalano M, O\u2019Driscoll L. Inhibiting extracellular vesicles formation and release: a review of EV inhibitors. J Extracell Vesicles. 2020;9(1):1703244.","journal-title":"J Extracell Vesicles"},{"issue":"3","key":"4396_CR131","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11060-013-1235-y","volume":"115","author":"NA Atai","year":"2013","unstructured":"Atai NA, Balaj L, van Veen H, Breakefield XO, Jarzyna PA, Van Noorden CJ, et al. Heparin blocks transfer of extracellular vesicles between donor and recipient cells. J Neurooncol. 2013;115(3):343\u201351.","journal-title":"J Neurooncol"},{"issue":"2","key":"4396_CR132","doi-asserted-by":"crossref","first-page":"e0148454","DOI":"10.1371\/journal.pone.0148454","volume":"11","author":"S Sento","year":"2016","unstructured":"Sento S, Sasabe E, Yamamoto T. Application of a Persistent Heparin Treatment Inhibits the Malignant Potential of Oral Squamous Carcinoma Cells Induced by Tumor Cell-Derived Exosomes. PLoS ONE. 2016;11(2):e0148454.","journal-title":"PLoS ONE"},{"issue":"2","key":"4396_CR133","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1039\/D5RA04927J","volume":"16","author":"S Sonar","year":"2026","unstructured":"Sonar S, Das A, Nyahatkar S, Dhar R, Kalele K, Balasubramaniam VRMT, et al. Hybrid exosomes: a rising horizon for precision cancer therapy. RSC Adv. 2026;16(2):1292\u2013309.","journal-title":"RSC Adv"},{"issue":"10","key":"4396_CR134","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1039\/D0BM00427H","volume":"8","author":"Y Ye","year":"2020","unstructured":"Ye Y, Zhang X, Xie F, Xu B, Xie P, Yang T, et al. An engineered exosome for delivering sgRNA:Cas9 ribonucleoprotein complex and genome editing in recipient cells. Biomater Sci. 2020;8(10):2966\u201376.","journal-title":"Biomater Sci"},{"key":"4396_CR135","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155785","volume":"266","author":"AK Balaraman","year":"2025","unstructured":"Balaraman AK, Babu MA, Moglad E, Mandaliya V, Rekha MM, Gupta S, et al. Exosome-mediated delivery of CRISPR-Cas9: A revolutionary approach to cancer gene editing. Pathol Res Pract. 2025;266:155785.","journal-title":"Pathol Res Pract"},{"issue":"5","key":"4396_CR136","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2021036301","volume":"38","author":"A Gebeyehu","year":"2021","unstructured":"Gebeyehu A, Kommineni N, Meckes DG Jr., Sachdeva MS. Role of Exosomes for Delivery of Chemotherapeutic Drugs. Crit Rev Ther Drug Carrier Syst. 2021;38(5):53\u201397.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"4396_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15010066","author":"A Akbari","year":"2022","unstructured":"Akbari A, Nazari-Khanamiri F, Ahmadi M, Shoaran M, Rezaie J. Engineered exosomes for tumor-targeted drug delivery: a focus on genetic and chemical functionalization. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics15010066.","journal-title":"Pharmaceutics"},{"issue":"3","key":"4396_CR138","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","volume":"12","author":"MS Kim","year":"2016","unstructured":"Kim MS, Haney MJ, Zhao Y, Mahajan V, Deygen I, Klyachko NL, et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine (Lond). 2016;12(3):655\u201364.","journal-title":"Nanomedicine (Lond)"},{"issue":"1","key":"4396_CR139","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nano.2017.09.011","volume":"14","author":"MS Kim","year":"2018","unstructured":"Kim MS, Haney MJ, Zhao Y, Yuan D, Deygen I, Klyachko NL, et al. Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations. Nanomedicine (Lond). 2018;14(1):195\u2013204.","journal-title":"Nanomedicine (Lond)"},{"issue":"5","key":"4396_CR140","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.7150\/ijbs.58786","volume":"17","author":"C Tian","year":"2021","unstructured":"Tian C, Yang Y, Bai B, Wang S, Liu M, Sun RC, et al. Potential of exosomes as diagnostic biomarkers and therapeutic carriers for doxorubicin-induced cardiotoxicity. Int J Biol Sci. 2021;17(5):1328\u201338.","journal-title":"Int J Biol Sci"},{"key":"4396_CR141","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1478-811X-11-88","volume":"11","author":"TA Shtam","year":"2013","unstructured":"Shtam TA, Kovalev RA, Varfolomeeva EY, Makarov EM, Kil YV, Filatov MV. Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell Commun Signal. 2013;11:88.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"4396_CR142","doi-asserted-by":"publisher","first-page":"5897","DOI":"10.1038\/s41598-021-85242-1","volume":"11","author":"Y Kase","year":"2021","unstructured":"Kase Y, Uzawa K, Wagai S, Yoshimura S, Yamamoto J-I, Toeda Y, et al. Engineered exosomes delivering specific tumor-suppressive RNAi attenuate oral cancer progression. Scientific Reports. 2021;11(1):5897.","journal-title":"Scientific Reports"},{"key":"4396_CR143","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1447953","volume":"11","author":"P Ubanako","year":"2024","unstructured":"Ubanako P, Mirza S, Ruff P, Penny C. Exosome-mediated delivery of siRNA molecules in cancer therapy: triumphs and challenges. Frontiers in Molecular Biosciences. 2024;11:1447953.","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"5","key":"4396_CR144","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.7150\/thno.17092","volume":"7","author":"D Bellavia","year":"2017","unstructured":"Bellavia D, Raimondo S, Calabrese G, Forte S, Cristaldi M, Patinella A, et al. Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo chronic myelogenous leukemia cell growth. Theranostics. 2017;7(5):1333\u201345.","journal-title":"Theranostics"},{"issue":"3","key":"4396_CR145","volume":"25","author":"L Chen","year":"2023","unstructured":"Chen L, Xie T, Wei B, Di D-L. Tumour\u2011derived exosomes and their emerging roles in leukaemia (review). Exp Ther Med. 2023;25(3):126.","journal-title":"Exp Ther Med"},{"key":"4396_CR146","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00782","volume":"9","author":"H Monfared","year":"2019","unstructured":"Monfared H, Jahangard Y, Nikkhah M, Mirnajafi-Zadeh J, Mowla SJ. Potential therapeutic effects of exosomes packed with a miR-21-sponge construct in a rat model of glioblastoma. Front Oncol. 2019;9:782.","journal-title":"Front Oncol"},{"issue":"12","key":"4396_CR147","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","volume":"14","author":"A Akinc","year":"2019","unstructured":"Akinc A, Maier MA, Manoharan M, Fitzgerald K, Jayaraman M, Barros S, et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nat Nanotechnol. 2019;14(12):1084\u20137.","journal-title":"Nat Nanotechnol"},{"issue":"5","key":"4396_CR148","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov. 2019;18(5):358\u201378.","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"4396_CR149","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","volume":"16","author":"IK Herrmann","year":"2021","unstructured":"Herrmann IK, Wood MJA, Fuhrmann G. Extracellular vesicles as a next-generation drug delivery platform. Nature Nanotechnology. 2021;16(7):748\u201359.","journal-title":"Nature Nanotechnology"},{"issue":"12","key":"4396_CR150","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078\u201394.","journal-title":"Nat Rev Mater"},{"issue":"4","key":"4396_CR151","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","volume":"8","author":"SA Dilliard","year":"2023","unstructured":"Dilliard SA, Siegwart DJ. Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. Nat Rev Mater. 2023;8(4):282\u2013300.","journal-title":"Nat Rev Mater"},{"issue":"11","key":"4396_CR152","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","volume":"15","author":"R Tenchov","year":"2021","unstructured":"Tenchov R, Bird R, Curtze AE, Zhou Q. Lipid NanoparticlesFrom Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement. ACS Nano. 2021;15(11):16982\u20137015.","journal-title":"ACS Nano"},{"issue":"18","key":"4396_CR153","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, et al. Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy. N Engl J Med. 2017;377(18):1713\u201322.","journal-title":"N Engl J Med"},{"key":"4396_CR154","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","volume":"8","author":"P Colella","year":"2018","unstructured":"Colella P, Ronzitti G, Mingozzi F. Emerging Issues in AAV-Mediated In Vivo Gene Therapy. Mol Ther Methods Clin Dev. 2018;8:87\u2013104.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"4396_CR155","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ymthe.2019.12.010","volume":"28","author":"H Costa Verdera","year":"2020","unstructured":"Costa Verdera H, Kuranda K, Mingozzi F. AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer. Mol Ther. 2020;28(3):723\u201346.","journal-title":"Mol Ther"},{"issue":"6","key":"4396_CR156","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1007\/s11095-014-1593-y","volume":"32","author":"T Yang","year":"2015","unstructured":"Yang T, Martin P, Fogarty B, Brown A, Schurman K, Phipps R, et al. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio. Pharm Res. 2015;32(6):2003\u201314.","journal-title":"Pharm Res"},{"issue":"8","key":"4396_CR157","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1007\/s12035-023-03365-0","volume":"60","author":"SH Khatami","year":"2023","unstructured":"Khatami SH, Karami N, Taheri-Anganeh M, Taghvimi S, Tondro G, Khorsand M, et al. Exosomes: Promising Delivery Tools for Overcoming Blood-Brain Barrier and Glioblastoma Therapy. Mol Neurobiol. 2023;60(8):4659\u201378.","journal-title":"Mol Neurobiol"},{"key":"4396_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjprs.2025.05.001","author":"H Chen","year":"2025","unstructured":"Chen H, Li Q. Recent advances in scalable exosome production: challenges and innovations. Chinese Journal of Plastic and Reconstructive Surgery. 2025. https:\/\/doi.org\/10.1016\/j.cjprs.2025.05.001.","journal-title":"Chinese Journal of Plastic and Reconstructive Surgery"},{"issue":"5","key":"4396_CR159","doi-asserted-by":"crossref","first-page":"284","DOI":"10.14348\/molcells.2022.2033","volume":"45","author":"SH Ahn","year":"2022","unstructured":"Ahn SH, Ryu SW, Choi H, You S, Park J, Choi C. Manufacturing Therapeutic Exosomes: from Bench to Industry. Mol Cells. 2022;45(5):284\u201390.","journal-title":"Mol Cells"},{"key":"4396_CR160","doi-asserted-by":"publisher","DOI":"10.3390\/cells12101416","author":"H Zeng","year":"2023","unstructured":"Zeng H, Guo S, Ren X, Wu Z, Liu S, Yao X. Current strategies for exosome cargo loading and targeting delivery. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12101416.","journal-title":"Cells"},{"key":"4396_CR161","doi-asserted-by":"crossref","first-page":"100424","DOI":"10.1016\/j.dmpk.2021.100424","volume":"41","author":"Y Suzuki","year":"2021","unstructured":"Suzuki Y, Ishihara H. Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs. Drug Metab Pharmacokinet. 2021;41:100424.","journal-title":"Drug Metab Pharmacokinet"},{"issue":"7659","key":"4396_CR162","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature22341","volume":"546","author":"S Kamerkar","year":"2017","unstructured":"Kamerkar S, LeBleu VS, Sugimoto H, Yang S, Ruivo CF, Melo SA, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546(7659):498\u2013503.","journal-title":"Nature"},{"key":"4396_CR163","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17060940","author":"E Youssef","year":"2025","unstructured":"Youssef E, Palmer D, Fletcher B, Vaughn R. Exosomes in precision oncology and beyond: from bench to bedside in diagnostics and therapeutics. Cancers (Basel). 2025. https:\/\/doi.org\/10.3390\/cancers17060940.","journal-title":"Cancers (Basel)"},{"key":"4396_CR164","doi-asserted-by":"crossref","first-page":"123752","DOI":"10.1016\/j.lfs.2025.123752","volume":"375","author":"V Picchio","year":"2025","unstructured":"Picchio V, Pontecorvi V, Dhori X, Bordin A, Floris E, Cozzolino C, et al. The emerging role of artificial intelligence applied to exosome analysis: from cancer biology to other biomedical fields. Life Sci. 2025;375:123752.","journal-title":"Life Sci"},{"issue":"4","key":"4396_CR165","first-page":"61","volume":"14","author":"SC Tsai","year":"2024","unstructured":"Tsai SC, Wan BH, Tsai FJ, Yang JS. Artificial intelligence (AI)-powered bibliometric analysis of global trends in mesenchymal stem cells (MSCs)-derived exosome research: 2014\u20132023. Biomed (Taipei). 2024;14(4):61\u201377.","journal-title":"Biomed (Taipei)"},{"key":"4396_CR166","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering12050548","author":"MH Wang","year":"2025","unstructured":"Wang MH. Integrating artificial intelligence and precision therapeutics for advancing the diagnosis and treatment of age-related macular degeneration. Bioengineering. 2025. https:\/\/doi.org\/10.3390\/bioengineering12050548.","journal-title":"Bioengineering"},{"key":"4396_CR167","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146966","author":"RA Covache-Busuioc","year":"2025","unstructured":"Covache-Busuioc RA, Toader C, R\u0103doi MP, \u0218erban M. Precision recovery after spinal cord injury: integrating CRISPR technologies, AI-driven therapeutics, single-cell omics, and system neuroregeneration. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26146966.","journal-title":"Int J Mol Sci"},{"key":"4396_CR168","doi-asserted-by":"crossref","first-page":"123752","DOI":"10.1016\/j.lfs.2025.123752","volume":"375","author":"V Picchio","year":"2025","unstructured":"Picchio V, Pontecorvi V, Dhori X, Bordin A, Floris E, Cozzolino C, et al. The emerging role of artificial intelligence applied to exosome analysis: from cancer biology to other biomedical fields. Life Sci. 2025;375:123752.","journal-title":"Life Sci"},{"key":"4396_CR169","unstructured":"Moslehi D, Nahm WJ, Serwald G, Bigham Z, Nambudiri VE. Exosomes in precision dermatology: From biomarkers to targeted therapeutics in personalized care. Journal of the European Academy of Dermatology and Venereology.n\/a(n\/a)."},{"key":"4396_CR170","doi-asserted-by":"crossref","first-page":"114974","DOI":"10.1016\/j.addr.2023.114974","volume":"199","author":"ZF Greenberg","year":"2023","unstructured":"Greenberg ZF, Graim KS, He M. Towards artificial intelligence-enabled extracellular vesicle precision drug delivery. Adv Drug Deliv Rev. 2023;199:114974.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"4396_CR171","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","volume":"12","author":"MS Kim","year":"2016","unstructured":"Kim MS, Haney MJ, Zhao Y, Mahajan V, Deygen I, Klyachko NL, et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomed Nanotechnol Biol Med. 2016;12(3):655\u201364.","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"18","key":"4396_CR172","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.2217\/nnm-2016-0154","volume":"11","author":"M Hadla","year":"2016","unstructured":"Hadla M, Palazzolo S, Corona G, Caligiuri I, Canzonieri V, Toffoli G, et al. Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models. Nanomedicine. 2016;11(18):2431\u201341.","journal-title":"Nanomedicine"},{"issue":"5","key":"4396_CR173","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3109\/03639045.2015.1064941","volume":"42","author":"S Chaurasia","year":"2016","unstructured":"Chaurasia S, Chaubey P, Patel RR, Kumar N, Mishra B. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies. Drug Dev Ind Pharm. 2016;42(5):694\u2013700.","journal-title":"Drug Dev Ind Pharm"},{"issue":"6","key":"4396_CR174","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1208\/s12248-017-0154-9","volume":"19","author":"F Aqil","year":"2017","unstructured":"Aqil F, Munagala R, Jeyabalan J, Agrawal AK, Gupta R. Exosomes for the enhanced tissue bioavailability and efficacy of curcumin. Aaps j. 2017;19(6):1691\u2013702.","journal-title":"Aaps j"},{"key":"4396_CR175","volume":"944","author":"BR S","year":"2025","unstructured":"S BR, Dhar R, Devi A. Exosomes-mediated CRISPR\/Cas delivery: a cutting-edge frontier in cancer gene therapy. Gene. 2025;944:149296.","journal-title":"Gene"},{"key":"4396_CR176","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202000875","author":"KM McAndrews","year":"2021","unstructured":"McAndrews KM, Xiao F, Chronopoulos A, LeBleu VS, Kugeratski FG, Kalluri R. Exosome-mediated delivery of CRISPR\/Cas9 for targeting of oncogenic KrasG12D in pancreatic cancer. Life science alliance. 2021. https:\/\/doi.org\/10.26508\/lsa.202000875.","journal-title":"Life science alliance"},{"issue":"16","key":"4396_CR177","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1038\/s41388-017-0116-9","volume":"37","author":"K O\u2019brien","year":"2018","unstructured":"O\u2019brien K, Khan S, Gilligan K, Zafar H, Lalor P, Glynn C, et al. Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379. Oncogene. 2018;37(16):2137\u201349.","journal-title":"Oncogene"},{"issue":"1","key":"4396_CR178","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13046-019-1512-5","volume":"39","author":"G Lou","year":"2020","unstructured":"Lou G, Chen L, Xia C, Wang W, Qi J, Li A, et al. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway. J Exp Clin Cancer Res. 2020;39(1):4.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"4396_CR179","doi-asserted-by":"crossref","first-page":"e0152090","DOI":"10.1371\/journal.pone.0152090","volume":"11","author":"C Pan","year":"2016","unstructured":"Pan C, Wang X, Shi K, Zheng Y, Li J, Chen Y, et al. MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism. PLoS ONE. 2016;11(5):e0152090.","journal-title":"PLoS ONE"},{"issue":"4","key":"4396_CR180","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/mt.2008.1","volume":"16","author":"S Dai","year":"2008","unstructured":"Dai S, Wei D, Wu Z, Zhou X, Wei X, Huang H, et al. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther. 2008;16(4):782\u201390.","journal-title":"Mol Ther"},{"issue":"3","key":"4396_CR181","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cjprs.2025.05.001","volume":"7","author":"H Chen","year":"2025","unstructured":"Chen H, Li Q. Recent advances in scalable exosome production: Challenges and innovations. Chin J Plast Reconstr Surg. 2025;7(3):149\u201363.","journal-title":"Chin J Plast Reconstr Surg"},{"issue":"2","key":"4396_CR182","doi-asserted-by":"crossref","first-page":"200800","DOI":"10.1016\/j.omton.2024.200800","volume":"32","author":"AT Gharavi","year":"2024","unstructured":"Gharavi AT, Irian S, Niknejad A, Parang K, Salimi M. Harnessing exosomes as a platform for drug delivery in breast cancer: A systematic review for in vivo and in vitro studies. Mol Ther Oncol. 2024;32(2):200800.","journal-title":"Mol Ther Oncol"},{"key":"4396_CR183","doi-asserted-by":"crossref","first-page":"117019","DOI":"10.1016\/j.bcp.2025.117019","volume":"239","author":"SG Gabaran","year":"2025","unstructured":"Gabaran SG, Nejati V, Dilsiz N, Rezaie J. An updated review on the inhibition of exosome biogenesis, release, and uptake: a potential anticancer approach. Biochem Pharmacol. 2025;239:117019.","journal-title":"Biochem Pharmacol"},{"key":"4396_CR184","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.2147\/IJN.S501843","volume":"20","author":"W Xu","year":"2025","unstructured":"Xu W, Jieda X, Wu Y, Du F, Ma L, Luo L, et al. Safety, Efficacy and Bio-Distribution Analysis of Exosomes Derived From Human Umbilical Cord Mesenchymal Stem Cells for Effective Treatment of Bronchopulmonary Dysplasia by Intranasal Administration in Mice Model. Int J Nanomed. 2025;20:2521\u201353.","journal-title":"Int J Nanomed"},{"key":"4396_CR185","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.261582","author":"MJ Medlyn","year":"2024","unstructured":"Medlyn MJ, Maeder E, Bradley C, Phatarpekar P, Ham H, Billadeau DD. MADD regulates natural killer cell degranulation through Rab27a activation. J Cell Sci. 2024. https:\/\/doi.org\/10.1242\/jcs.261582.","journal-title":"J Cell Sci"},{"key":"4396_CR186","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/bs.apha.2024.10.015","volume":"102","author":"M Huang","year":"2025","unstructured":"Huang M, Stremlau M, Zavras J, Zivko C, Thomas AG, Pietri P, et al. Neutral sphingomyelinase 2: A promising drug target for CNS disease. Adv Pharmacol. 2025;102:65\u2013101.","journal-title":"Adv Pharmacol"},{"issue":"1","key":"4396_CR187","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13041-021-00776-9","volume":"14","author":"C Zhu","year":"2021","unstructured":"Zhu C, Bilousova T, Focht S, Jun M, Elias CJ, Melnik M, et al. Pharmacological inhibition of nSMase2 reduces brain exosome release and \u03b1-synuclein pathology in a Parkinson\u2019s disease model. Mol Brain. 2021;14(1):70.","journal-title":"Mol Brain"},{"issue":"9","key":"4396_CR188","doi-asserted-by":"crossref","first-page":"e12870","DOI":"10.1371\/journal.pone.0012870","volume":"5","author":"D Liu","year":"2010","unstructured":"Liu D, Meckel T, Long EO. Distinct Role of Rab27a in Granule Movement at the Plasma Membrane and in the Cytosol of NK Cells. PLoS ONE. 2010;5(9):e12870.","journal-title":"PLoS ONE"},{"issue":"3","key":"4396_CR189","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cytogfr.2014.10.001","volume":"26","author":"E Brisse","year":"2015","unstructured":"Brisse E, Wouters CH, Matthys P. Hemophagocytic lymphohistiocytosis (HLH): a heterogeneous spectrum of cytokine-driven immune disorders. Cytokine Growth Factor Rev. 2015;26(3):263\u201380.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"S13","key":"4396_CR190","doi-asserted-by":"crossref","first-page":"e074880","DOI":"10.1002\/alz.074880","volume":"19","author":"F Mowry","year":"2023","unstructured":"Mowry F, Jin S, Quadri Z, Bieberich E, Yang Y, Yang Y. Chronic nSMase2 Inhibition Suppresses Neuronal Exosome Spreading In Vivo & Induces Sex-Specific Attenuation of AD Pathology in APPNL-F\/NL-F Knock-In Mice. Alzheimer\u2019s Dement. 2023;19(S13):e074880.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"5","key":"4396_CR191","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1007\/s12035-022-02747-0","volume":"59","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Quadri Z, Crivelli SM, Elsherbini A, Zhang L, Tripathi P, et al. Neutral Sphingomyelinase 2 Mediates Oxidative Stress Effects on Astrocyte Senescence and Synaptic Plasticity Transcripts. Mol Neurobiol. 2022;59(5):3233\u201353.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"4396_CR192","first-page":"155932582513444","volume":"23","author":"X Hao","year":"2025","unstructured":"Hao X, Liu Z, Ma F, Li T, Liu C, Wang N, et al. Exosome-Based Liquid Biopsy in Early Screening and Diagnosis of Cancers. Dose Response. 2025;23(2):15593258251344480.","journal-title":"Dose Response"},{"issue":"1","key":"4396_CR193","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","volume":"9","author":"L Ma","year":"2024","unstructured":"Ma L, Guo H, Zhao Y, Liu Z, Wang C, Bu J, et al. Liquid biopsy in cancer: current status, challenges and future prospects. Signal Transduct Target Therapy. 2024;9(1):336.","journal-title":"Signal Transduct Target Therapy"},{"key":"4396_CR194","doi-asserted-by":"crossref","first-page":"100144","DOI":"10.1016\/j.jlb.2024.100144","volume":"4","author":"S Nyahatkar","year":"2024","unstructured":"Nyahatkar S, Kalele K. Exosomes-based liquid biopsy: An effective approach for drugs and therapeutics resistance screening in cancer. J Liquid Biopsy. 2024;4:100144.","journal-title":"J Liquid Biopsy"},{"key":"4396_CR195","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14225618","author":"SJ Kim","year":"2022","unstructured":"Kim SJ, Ryu KJ, Park B, Yoon SE, Cho J, Park Y, et al. Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK\/T-Cell Lymphoma. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14225618.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"4396_CR196","first-page":"4498","volume":"10","author":"JW Li","year":"2020","unstructured":"Li JW, Wei P, Guo Y, Shi D, Yu BH, Su YF, et al. Clinical significance of circulating exosomal PD-L1 and soluble PD-L1 in extranodal NK\/T-cell lymphoma, nasal-type. Am J Cancer Res. 2020;10(12):4498\u2013512.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"4396_CR197","doi-asserted-by":"publisher","first-page":"6952","DOI":"10.1038\/s41598-023-33128-9","volume":"13","author":"K Shin","year":"2023","unstructured":"Shin K, Kim J, Park SJ, Lee MA, Park JM, Choi M-G, et al. Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy. Sci Rep. 2023;13(1):6952.","journal-title":"Sci Rep"},{"issue":"1","key":"4396_CR198","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41698-022-00287-3","volume":"6","author":"Z-L Yu","year":"2022","unstructured":"Yu Z-L, Liu J-Y, Chen G. Small extracellular vesicle PD-L1 in cancer: the knowns and unknowns. npj Precision Oncol. 2022;6(1):42.","journal-title":"npj Precision Oncol"},{"issue":"1","key":"4396_CR199","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.","journal-title":"J Extracell Vesicles"},{"issue":"5","key":"4396_CR200","doi-asserted-by":"crossref","DOI":"10.1007\/s00604-025-07147-4","volume":"192","author":"S Escudero-Cernuda","year":"2025","unstructured":"Escudero-Cernuda S, Eiro N, Fraile M, Vizoso FJ, Fern\u00e1ndez-Colomer B, Fern\u00e1ndez-S\u00e1nchez ML. Limitations and challenges in the characterization of extracellular vesicles from stem cells and serum. Mikrochim Acta. 2025;192(5):311.","journal-title":"Mikrochim Acta"},{"issue":"2","key":"4396_CR201","doi-asserted-by":"crossref","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, Goberdhan DCI, O\u2019Driscoll L, Buzas EI, Blenkiron C, Bussolati B, et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024;13(2):e12404.","journal-title":"J Extracell Vesicles"},{"key":"4396_CR202","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2025.03.042","author":"E Zakhem","year":"2025","unstructured":"Zakhem E, Lenzini S. Single Extracellular Vesicle Profiling: Harnessing NanoFlow Cytometry for Quantitative Surface Marker Analysis. Cytotherapy. 2025. https:\/\/doi.org\/10.1016\/j.jcyt.2025.03.042.","journal-title":"Cytotherapy"},{"key":"4396_CR203","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18061153","author":"R Szatanek","year":"2017","unstructured":"Szatanek R, Baj-Krzyworzeka M, Zimoch J, Lekka M, Siedlar M, Baran J. The Methods of Choice for Extracellular Vesicles (EVs) Characterization. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18061153.","journal-title":"Int J Mol Sci"},{"key":"4396_CR204","volume-title":"The advances and applications of characterization technique for exosomes: from dynamic light scattering to super-resolution imaging technology","year":"2024","unstructured":"Wu S, Zhao Y, Zhang Z, Zuo C, Wu H, Liu Y, editors. The advances and applications of characterization technique for exosomes: from dynamic light scattering to super-resolution imaging technology. Photonics: MDPI; 2024."},{"issue":"4","key":"4396_CR205","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12551-016-0218-6","volume":"8","author":"J Stetefeld","year":"2016","unstructured":"Stetefeld J, McKenna SA, Patel TR. Dynamic light scattering: a practical guide and applications in biomedical sciences. Biophys Rev. 2016;8(4):409\u201327.","journal-title":"Biophys Rev"},{"issue":"9","key":"4396_CR206","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s11051-014-2583-z","volume":"16","author":"V Palmieri","year":"2014","unstructured":"Palmieri V, Lucchetti D, Gatto I, Maiorana A, Marcantoni M, Maulucci G, et al. Dynamic light scattering for the characterization and counting of extracellular vesicles: a powerful noninvasive tool. J Nanopart Res. 2014;16(9):2583.","journal-title":"J Nanopart Res"},{"key":"4396_CR207","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-4939-6728-5_2","volume":"1545","author":"SL Maas","year":"2017","unstructured":"Maas SL, Broekman ML, de Vrij J. Tunable resistive pulse sensing for the characterization of extracellular vesicles. Methods Mol Biol. 2017;1545:21\u201333.","journal-title":"Methods Mol Biol"},{"key":"4396_CR208","doi-asserted-by":"publisher","DOI":"10.3390\/cells14130989","author":"D Polignano","year":"2025","unstructured":"Polignano D, Barreca V, Sanchez M, Sargiacomo M, Fiani ML. A Simple and Scalable Assay for Multiplexed Flow Cytometric Profiling of Surface Markers on Small Extracellular Vesicles. Cells. 2025. https:\/\/doi.org\/10.3390\/cells14130989.","journal-title":"Cells"},{"issue":"6","key":"4396_CR209","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/jth.14009","volume":"16","author":"E van der Pol","year":"2018","unstructured":"van der Pol E, Sturk A, van Leeuwen T, Nieuwland R, Coumans F, Mobarrez F, et al. Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation. Journal of thrombosis and haemostasis. 2018;16(6):1236\u201345.","journal-title":"Journal of thrombosis and haemostasis"},{"key":"4396_CR210","doi-asserted-by":"publisher","DOI":"10.3390\/nano15151153","author":"S Lee","year":"2025","unstructured":"Lee S, Moussa NAM, Kang SH. Plasmonic Nanostructures for Exosome Biosensing: Enabling High-Sensitivity Diagnostics. Nanomaterials. 2025. https:\/\/doi.org\/10.3390\/nano15151153.","journal-title":"Nanomaterials"},{"issue":"7","key":"4396_CR211","doi-asserted-by":"crossref","first-page":"2300999","DOI":"10.1002\/lpor.202300999","volume":"19","author":"Y Hu","year":"2025","unstructured":"Hu Y, Wang Y, Zhang Y, Yang H. Recent advances in plasmonic sensing techniques for exosome detection and composition analysis. Laser Photonics Rev. 2025;19(7):2300999.","journal-title":"Laser Photonics Rev"},{"issue":"12","key":"4396_CR212","doi-asserted-by":"crossref","first-page":"e70020","DOI":"10.1002\/jev2.70020","volume":"13","author":"D Fochtman","year":"2024","unstructured":"Fochtman D, Marczak L, Pietrowska M, Wojakowska A. Challenges of MS-based small extracellular vesicles proteomics. J Extracell Vesicles. 2024;13(12):e70020.","journal-title":"J Extracell Vesicles"},{"key":"4396_CR213","volume":"111","author":"M Giallombardo","year":"2016","unstructured":"Giallombardo M, Borr\u00e1s JC, Castiglia M, Van Der Steen N, Mertens I, Pauwels P, et al. Exosomal miRNA analysis in non-small cell lung cancer (NSCLC) patients\u2019 plasma through qPCR: a feasible liquid biopsy tool. J Vis Exp. 2016;111:53900.","journal-title":"J Vis Exp"},{"issue":"5","key":"4396_CR214","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.3390\/ijms23052461","volume":"23","author":"J Wang","year":"2022","unstructured":"Wang J, Yue B-L, Huang Y-Z, Lan X-Y, Liu W-J, Chen H. Exosomal RNAs: novel potential biomarkers for diseases\u2014a review. Int J Mol Sci. 2022;23(5):2461.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"4396_CR215","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3390\/pharmaceutics16111394","volume":"16","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Lan M, Chen Y. Minimal Information for Studies of Extracellular Vesicles (MISEV): Ten-Year Evolution (2014\u20132023). Pharmaceutics. 2024;16(11):1394.","journal-title":"Pharmaceutics"},{"key":"4396_CR216","doi-asserted-by":"publisher","DOI":"10.3390\/metabo14080461","author":"J von Gerichten","year":"2024","unstructured":"von Gerichten J, Saunders K, Bailey MJ, Gethings LA, Onoja A, Geifman N, et al. Challenges in Lipidomics Biomarker Identification: Avoiding the Pitfalls and Improving Reproducibility. Metabolites. 2024. https:\/\/doi.org\/10.3390\/metabo14080461.","journal-title":"Metabolites"},{"issue":"10","key":"4396_CR217","doi-asserted-by":"crossref","first-page":"103751","DOI":"10.1016\/j.drudis.2023.103751","volume":"28","author":"G Astarita","year":"2023","unstructured":"Astarita G, Kelly RS, Lasky-Su J. Metabolomics and lipidomics strategies in modern drug discovery and development. Drug Discov Today. 2023;28(10):103751.","journal-title":"Drug Discov Today"},{"key":"4396_CR218","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13122970","author":"E S\u00e1nchez-Vizca\u00edno Mengual","year":"2025","unstructured":"S\u00e1nchez-Vizca\u00edno Mengual E, Cordero L, Pinto H. Human Blood Exosomes: Isolation and Characterization Methods, Variability, and the Need for Standardized Protocols-A Review. Biomedicines. 2025. https:\/\/doi.org\/10.3390\/biomedicines13122970.","journal-title":"Biomedicines"},{"key":"4396_CR219","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.aca.2020.09.060","volume":"1137","author":"T Xu","year":"2020","unstructured":"Xu T, Hu C, Xuan Q, Xu G. Recent advances in analytical strategies for mass spectrometry-based lipidomics. Anal Chim Acta. 2020;1137:156\u201369.","journal-title":"Anal Chim Acta"},{"issue":"8","key":"4396_CR220","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3390\/pharmaceutics17080990","volume":"17","author":"N Verma","year":"2025","unstructured":"Verma N, Arora S. Navigating the global regulatory landscape for exosome-based therapeutics: challenges, strategies, and future directions. Pharmaceutics. 2025;17(8):990.","journal-title":"Pharmaceutics"},{"issue":"5","key":"4396_CR221","doi-asserted-by":"crossref","first-page":"284","DOI":"10.14348\/molcells.2022.2033","volume":"45","author":"S-H Ahn","year":"2022","unstructured":"Ahn S-H, Ryu S-W, Choi H, You S, Park J, Choi C. Manufacturing therapeutic exosomes: from bench to industry. Mol Cells. 2022;45(5):284\u201390.","journal-title":"Mol Cells"},{"issue":"2","key":"4396_CR222","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/trf.17156","volume":"63","author":"JA Korchak","year":"2023","unstructured":"Korchak JA, Wiest EF, Zubair AC. How do we assess batch-to-batch consistency between extracellular vesicle products? Transfusion. 2023;63(2):279\u201387.","journal-title":"Transfusion"},{"issue":"1","key":"4396_CR223","volume":"9","author":"JA Welsh","year":"2020","unstructured":"Welsh JA, van der Pol E, Bettin BA, Carter DRF, Hendrix A, Lenassi M, et al. Towards defining reference materials for measuring extracellular vesicle refractive index, epitope abundance, size and concentration. Journal of Extracellular Vesicles. 2020;9(1):1816641.","journal-title":"Journal of Extracellular Vesicles"},{"issue":"13","key":"4396_CR224","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310477","volume":"24","author":"R Qazi","year":"2023","unstructured":"Qazi R, Sajid Z, Zhao C, Hussain I, Iftikhar F, Jameel M, et al. Lyophilization based isolation of exosomes. International journal of molecular sciences. 2023;24(13):10477.","journal-title":"International journal of molecular sciences"},{"key":"4396_CR225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2024.100147","volume":"4","author":"A Nadeau","year":"2024","unstructured":"Nadeau A, Burnier JV. With >\u20091000 authors, the updated \u201cMinimum information for studies of extracellular vesicles\u201d (MISEV) promotes rigor, reproducibility, and transparency in the liquid biopsy field. J Liq Biopsy. 2024;4:100147.","journal-title":"J Liq Biopsy"},{"key":"4396_CR226","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113872","volume":"176","author":"R Poupardin","year":"2021","unstructured":"Poupardin R, Wolf M, Strunk D. Adherence to minimal experimental requirements for defining extracellular vesicles and their functions. Advanced Drug Delivery Reviews. 2021;176:113872.","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"4","key":"4396_CR227","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/hcs2.70028","volume":"4","author":"Q Li","year":"2025","unstructured":"Li Q, Li Y, Shao J, Sun J, Hu L, Yun X, et al. Exploring regulatory frameworks for exosome therapy: insights and perspectives. Health Care Science. 2025;4(4):299\u2013309.","journal-title":"Health Care Science"},{"issue":"1","key":"4396_CR228","volume":"10","author":"G Xu","year":"2025","unstructured":"Xu G, Jin J, Fu Z, Wang G, Lei X, Xu J, et al. Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies. Signal Transduction and Targeted Therapy. 2025;10(1):255.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"4396_CR229","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12943-025-02372-0","volume":"24","author":"JJJ Liu","year":"2025","unstructured":"Liu JJJ, Liu D, To SKY, Wong AST. Exosomes in cancer nanomedicine: biotechnological advancements and innovations. Mol Cancer. 2025;24(1):166.","journal-title":"Mol Cancer"},{"key":"4396_CR230","volume":"114","author":"F Maghami","year":"2025","unstructured":"Maghami F, Samsami Y, Haghshenas M, Zarghami S, Tarrah P, Suri F, et al. Exosome-based drug delivery in cancer therapy: advances and future perspectives. J Drug Deliv Sci Technol. 2025;114:107453.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"9","key":"4396_CR231","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2174\/1570159X21666230216095938","volume":"21","author":"Q Qu","year":"2023","unstructured":"Qu Q, Fu B, Long Y, Liu ZY, Tian XH. Current strategies for promoting the large-scale production of exosomes. Curr Neuropharmacol. 2023;21(9):1964\u201379.","journal-title":"Curr Neuropharmacol"},{"issue":"8","key":"4396_CR232","volume":"17","author":"CK Wang","year":"2024","unstructured":"Wang CK, Tsai TH, Lee CH. Regulation of exosomes as biologic medicines: regulatory challenges faced in exosome development and manufacturing processes. Clin Transl Sci. 2024;17(8):e13904.","journal-title":"Clin Transl Sci"},{"issue":"1","key":"4396_CR233","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12951-025-03352-8","volume":"23","author":"S Mehdizadeh","year":"2025","unstructured":"Mehdizadeh S, Mamaghani M, Hassanikia S, Pilehvar Y, Ertas YN. Exosome-powered neuropharmaceutics: unlocking the blood-brain barrier for next-gen therapies. J Nanobiotechnol. 2025;23(1):329.","journal-title":"J Nanobiotechnol"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04396-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04396-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04396-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:26:37Z","timestamp":1791973597000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04396-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":233,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4396"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04396-y","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"339"}}